Riskpilot← Back to searchSign inGet full accessEmergaLab AB
ABActiveOrg 5568713860Viktoriagatan 18 A Lgh 1201Other education n.e.c. · NACE 8559Est. 20111 employees
Revenue 2024
SEK 904K
-44% vs 2023
EBITDA margin
19.3%
-59% vs 2023
Equity ratio
24.1%
Financial strength
Net profit 2024
SEK 164K
-53% vs 2023
| Revenue | SEK 904K | -44% |
| EBITDA | SEK 174K | -59% |
| Net profit | SEK 164K | -53% |
| Total assets | SEK 996K | +22% |
| Equity | SEK 241K | -50% |
| Employees | 1 | — |
Legal name
EmergaLab AB
Org number
5568713860
Legal form
Aktiebolag
NACE code
8559 · Other education n.e.c.
Founded
9 november 2011
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva verksamhets- utveckling med fokus på utvärdering och utbildning samt därmed förenlig verksamhet.
Address
Viktoriagatan 18 A Lgh 1201
Email
lejla.mundzic@emerga.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 352 | 2 911 | 1 762 | 1 606 | 904 |
| Staff expenses | — | — | −649 | — | −523 |
| EBITDA | 143 | −138 | 647 | 427 | 174 |
| Depreciation & amort. | −6 | −6 | −3 | −0 | — |
| EBIT | 137 | −144 | 644 | 427 | 174 |
| Net financials | −7 | −12 | 1 | 8 | 2 |
| Profit before tax | 93 | 13 | 644 | 436 | 223 |
| Tax | −25 | −11 | −139 | −90 | −60 |
| Net profit | 68 | 2 | 506 | 346 | 164 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 178 | 1 691 | 1 137 | 815 | 996 |
| Equity | 633 | 556 | 631 | 477 | 241 |
| Long-term debt | 0 | 0 | — | 0 | — |
| Short-term debt | 1 287 | 1 048 | 418 | 250 | 716 |
| Total debt | 1 287 | 1 048 | 418 | 250 | 716 |
EBITDA margin
19.3%
This company
15.8%
Market median
+22% vs market
20202024
Equity ratio
24.1%
This company
38.2%
Market median
-37% vs market
20202024
Return on equity
68.0%
This company
18.4%
Market median
+270% vs market
20202024
Net profit margin
18.1%
This company
8.1%
Market median
+123% vs market
20202024
Asset turnover
0.91×
This company
1.12×
Market median
+19% vs market
20202024
Debt / equity
3.14×
This company
0.62×
Market median
-406% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LM Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2021 | |
| Former (1) | ||
| Board of Directors | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of EmergaLab AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lejla Mundzic | Chief Executive Officer | 0 companies |
| Heléne Maria Elisabeth Abiri | Board of Directors | 0 companies |
| Emir Mundzic | Deputy Board Member | 0 companies |